下一代细胞系用于描述不同的蛋白酶体形式及其在癌症中的影响
Alexander Burov1, Anastasia Yakovleva2,3,4, Georgy Linovskiy5,6
1Laboratory of Regulation of Intracellular Proteolysis, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Frontiers in immunology
|January 1, 2026
概括
研究人员开发了新的癌症细胞系来研究蛋白质酶子类型. 这些细胞系允许构成性和免疫蛋白质体的可视化和歧视,有助于理解它们在癌症中的独特功能.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 蛋白质体对于细胞内蛋白质降解至关重要,存在于构成性,免疫性和中间形式.
- 这些蛋白酶子类型在它们的催化β子单元上有所不同,影响细胞过程,如新陈代谢,基因表达和免疫信号.
- 了解每个蛋白酶子类型的特定生物功能是必不可少的,但仍然不完全定义.
研究的目的:
- 开发新的实验系统来剖析蛋白质酶子类型的不同功能.
- 为了使细胞内的构成性,中间性和免疫蛋白质体之间的可视化和区分.
- 为评估化合物对癌症模型中蛋白质酶活性的影响提供一个平台.
主要方法:
- 使用CRISPR/Cas9尼克酶技术生成癌细胞系 (SW620B8-mCherry和TZM-blB8-mCherry) 的研究.
- 将光蛋白基因 (eGFP,PS-CFP2) 插入编码蛋白质酶子单元 (PSMB5,PSMB10) 的基因中,以表达化学子单元.
- 利用显微镜技术,包括多光子显微镜,以在体外和体内可视化蛋白质酶体的定位和行为.
主要成果:
- 成功生成了具有强大的表达和光标记蛋白酶子单元集成的细胞系.
- 在TZM-blB8-mCherryB10-CFP细胞中展示了中间和免疫蛋白质体的可视化,并在SW620B8-mCherryB5-GFP细胞中区分构成性和β5i-蛋白质体.
- 观察到瘤中的蛋白质酶丰富的包容,并建议它们可能从癌细胞中释放出来.
结论:
- 产生的细胞系作为研究蛋白酶子类型功能的新平台.
- 这些工具有助于研究不同蛋白质体属性及其在细胞过程中的作用.
- 开发的系统允许对治疗化合物进行评估,这些化合物针对癌症中的蛋白质酶组.
相关概念视频
02:18The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
01:13The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
01:33Proteomics
9.2K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.2K
01:16Cell Lines
9.9K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
9.9K